These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23508305)

  • 1. Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy.
    Aranda J; Motiejunaite R; Silva P; Aiello LP; Kazlauskas A
    Diabetologia; 2013 Jun; 56(6):1444-53. PubMed ID: 23508305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy.
    Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM; Kangave D; Opdenakker G
    Acta Diabetol; 2013 Jun; 50(3):363-71. PubMed ID: 22864860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation.
    Chahed S; Leroyer AS; Benzerroug M; Gaucher D; Georgescu A; Picaud S; Silvestre JS; Gaudric A; Tedgui A; Massin P; Boulanger CM
    Diabetes; 2010 Mar; 59(3):694-701. PubMed ID: 20009085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
    Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
    Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.
    Noma H; Funatsu H; Yamashita H; Kitano S; Mishima HK; Hori S
    Arch Ophthalmol; 2002 Aug; 120(8):1075-80. PubMed ID: 12149062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous metabolomics profiling of proliferative diabetic retinopathy.
    Tomita Y; Cagnone G; Fu Z; Cakir B; Kotoda Y; Asakage M; Wakabayashi Y; Hellström A; Joyal JS; Talukdar S; Smith LEH; Usui Y
    Diabetologia; 2021 Jan; 64(1):70-82. PubMed ID: 33099660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
    Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
    J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Mohammad G; Siddiquei MM; Alam K; Mousa A; Opdenakker G
    Lipids Health Dis; 2014 Dec; 13():187. PubMed ID: 25496321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.
    Lange CAK; Stavrakas P; Luhmann UFO; de Silva DJ; Ali RR; Gregor ZJ; Bainbridge JWB
    Am J Ophthalmol; 2011 Sep; 152(3):406-412.e3. PubMed ID: 21723532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreous high expression level of netrin-1 in patients with proliferative diabetic retinopathy.
    Liu J; Xia X; Xiong S; Le Y; Xu H
    Eye Sci; 2011 Jun; 26(2):85-90, 120. PubMed ID: 21692205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
    Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
    Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
    Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
    Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
    Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK
    Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
    Chen W; Lu Q; Lu L; Guan H
    Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
    Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Suppression of Kallistatin on High-Glucose-Induced Proliferation of Retinal Endothelial Cells in Diabetic Retinopathy.
    Xing Q; Zhang G; Kang L; Wu J; Chen H; Liu G; Zhu R; Guan H; Lu P
    Ophthalmic Res; 2017; 57(3):141-149. PubMed ID: 27537690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.